Browsing OSU - Center for Health Sciences by Subject "clinical trials"
Now showing items 1-4 of 4
-
Comparison of adverse event reporting between adolescent and young adults and older adults with cancer enrolled in Phase II/III clinical trials
(Oklahoma State University Center for Health Sciences, 2023-02-17)Background: Momentum to improve cancer outcomes in adolescents and young adults (AYAs, diagnosed between 15-39 years of age) has been growing in recent years. However, there remains to be significant barriers to understanding ... -
COVID 19 and its effects on pediatric orthopaedic clinical trials
(Oklahoma State University Center for Health Sciences, 2022-02-18)Background: Clinical trials for the treatment of pediatric orthopaedics are critical to enhance the quality of life of these children. In response to the COVID-19 pandemic, the FDA updated guidance on conducting clinical ... -
Influence of COVID-19 on contraception: a cross-sectional analysis of disrupted clinical trials
(Oklahoma State University Center for Health Sciences, 2022-02-18)Background: The COVID-19 pandemic exacerbated barriers to contraceptive services and disrupted the progression of ongoing clinical trials (CTs) in several fields of medicine1–4, including contraceptive care. Further, ... -
Pediatric autoimmune clinical trial discontinuation and non-publication: An analysis of the National Library of Medicine
(Oklahoma State University Center for Health Sciences, 2023-02-17)Background: With the rise in pediatric autoimmune diseases in the United States, it is both clinically relevant and timely to analyze the safety, cost-effectiveness, and efficacy of treatment options. The methodical research ...